Xenon Pharmaceuticals (XENE) Prices 3.75M Share Common Offering at $16/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
After-Hours Stock Movers 01/22: (SLM) (EYE) (PTC) Higher; (PRA) (IMGN) (AVNW) Lower (more...)
January 22, 2020 5:42 PM ESTAfter-Hours Movers
SLM (NASDAQ: SLM) 19.8% HIGHER; reported Q4 EPS of $0.32, $0.02 better than the analyst estimate of $0.30.
National Vision (NYSE: EYE) 10.9% HIGHER; adds five additional vision centers, will now manage 231 vision centers within Walmart (WMT) stores
PTC (NASDAQ: PTC) 8.2% HIGHER; reported Q1 EPS of $0.57, $0.13 better than the analyst estimate of $0.44. Revenue for the quarter came in at $356.11 million versus the consensus estimate of $342.16 million. PTC sees FY2020... More
Xenon Pharmaceuticals (XENE) to Offer Common Stock
January 22, 2020 4:02 PM ESTXenon Pharmaceuticals Inc. (Nasdaq: XENE) announced that it has commenced an underwritten public offering of its common shares pursuant to its existing shelf registration statement. It is expected that the underwriters of the offering will be granted an option for a period of 30... More
